Midazolam inhibits tumor necrosis factor-α-induced endothelial activation: Involvement of the peripheral benzodiazepine receptor

Anesthesiology

Volumn 110, Issue 1, 2009, Pages 106-112

  Joo, Hee Kyoung ^a   Oh, Sae Cheol ^b   Cho, Eun Jung ^a   Park, Kyoung Sook ^c   Lee, Ji Young ^a   Lee, Eun Ji ^a   Lee, Sang Ki ^a   Kim, Hyo Shin ^a   Park, Jin Bong ^a   Jeon, Byeong Hwa ^a  

^a Chungnam National University   (South Korea)

^b St Mary's Hospital   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUMAZENIL; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; 4 AMINOBUTYRIC ACID RECEPTOR; TSPO PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MITOCHONDRION; MONOCYTE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MIDAZOLAM; RECEPTORS, GABA; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 58749106828     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318190bc69     Document Type: Article

References (25)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26
2. Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57:791-804
3. Braestrup C, Squires RF: Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A 1977; 74:3805-9
4. Le Fur G, Guilloux F, Rufat P, Benavides J, Uzan A, Renault C, Dubroeucq MC, Gueremy C: Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci 1983; 32:1849-56
5. Veenman L, Gavish M: The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006; 110:503-24
6. Kanto JH: Midazolam: The first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy 1985; 5:138-55
7. Wilms H, Claasen J, Rohl C, Sievers J, Deuschl G, Lucius R: Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: Evidence from activated microglial cells in vitro. Neurobiol Dis 2003; 14:417-24
8. Taupin V, Jayais P, Descamps-Latscha B, Cazalaa JB, Barrier G, Bach JF, Zavala F: Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes. J Neuroimmunol 1991; 35:13-9
9. Bidri M, Royer B, Averlant G, Bismuth G, Guillosson JJ, Arock M: Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines. Immunopharmacology 1999; 43:75-86
10. Kim SN, Son SC, Lee SM, Kim CS, Yoo DG, Lee SK, Hur GM, Park JB, Jeon BH: Midazolam inhibits proinflammatory mediators in the lipopolysaccharideactivated macrophage. ANESTHESIOLOGY 2006; 105:105-10
11. Miyawaki T, Sogawa N, Maeda S, Kohjitani A, Shimada M: Effect of midazolam on interleukin-6 mRNA expression in human peripheral blood mononuclear cells in the absence of lipopolysaccharide. Cytokine 2001; 15:320-7
12. Kim CS, Son SJ, Kim EK, Kim SN, Yoo DG, Kim HS, Ryoo SW, Lee SD, Irani K, Jeon BH: Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells. Cardiovasc Res 2006; 69:520-6
13. Matsumoto T, Ogata M, Koga K, Shigematsu A: Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother 1994; 38:812-6
14. Stoebner PE, Carayon P, Penarier G, Frechin N, Barneon G, Casellas P, Cano JP, Meynadier J, Meunier L: The expression of peripheral benzodiazepine receptors in human skin: The relationship with epidermal cell differentiation. Br J Dermatol 1999; 140:1010-6
15. Di Lisa F, Bernardi P: Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem 1998; 184:379-91
16. Hirsch JD, Beyer CF, Malkowitz L, Beer B, Blume AJ: Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol 1989; 35:157-63
17. Song YJ, Lee JY, Joo HK, Kim HS, Lee SK, Lee KH, Cho CH, Park JB, Jeon BH: Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation. Biochem Biophys Res Commun 2008; 368:68-73
18. Bowling AC, DeLorenzo RJ: Micromolar affinity benzodiazepine receptors: Identification and characterization in central nervous system. Science 1982; 216:1247-50
19. Ghori K, Harmon D, Walsh F, Shorten G: Effect of midazolam on in vitro cerebral endothelial ICAM-1 expression induced by astrocyte- conditioned medium. Eur J Anaesthesiol 2006; 23:788-92
20. Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM: Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun 1999; 265:457-61
21. Okaro AC, Fennell DA, Corbo M, Davidson BR, Cotter FE: Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells. Gut 2002; 51:556-61
22. Rao VL, Bowen KK, Rao AM, Dempsey RJ: Up-regulation of the peripheraltype benzodiazepine receptor expression and [(3)H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia. J Neurosci Res 2001; 64:493- 500
23. Weinbroum AA, Flaishon R, Sorkine P, Szold O, Rudick V: A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf 1997; 17:181-96
24. Fruebis J, Silvestre M, Shelton D, Napoli C, Palinski W: Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J Lipid Res 1999; 40: 1958-66
25. Colleoni M, Costa B, Gori E, Santagostino A: Biochemical characterization of the effects of the benzodiazepine, midazolam, on mitochondrial electron transfer. Pharmacol Toxicol 1996; 78:69-76